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In Japan, Buruli ulcer cases are often advanced, requiring surgical treatment. However,
extensive debridement is often difficult because of cosmetic and functional sequelae. More-
over, the lesions are complicated and composed of edematous erythema, necrotic ulcer,
and erythematous skin lesions caused by a paradoxical reaction, which also make it difficult
to perform adequate debridement.
Methodology/Principal findings
We performed quantitative polymerase chain reaction (PCR) analysis for IS2404 using 29
samples taken from mapping biopsy. We evaluated the relationship among mycobacterial
burden, histopathological findings, and clinical outcomes using 83 tissue samples taken
from mapping biopsy and debrided Buruli ulcer. On quantitative PCR, the Cp values of
IS2404 amplification were substantially different in each site. The major histological findings
could be divided into massive subcutaneous necrosis with scant inflammatory cell infiltration
and dense inflammatory cell infiltration. Of the 84 sites, 34 were subjected to repeated histo-
logical evaluations. In these sites, histological necrosis did not disappear over time despite
standard antibiotic treatment. In contrast, the ulcers were cured and no recurrences were
observed without resecting the 11 biopsied sites that lacked histological necrosis. Although
quantitative PCR revealed that a lower Cp value of IS2404 was associated with histological
massive necrosis, sites that showed lower Cp values clinically did not always need
debridement.
Conclusion/Significance
Our descriptive study revealed that the histological findings and amounts of mycobacterial
DNA differed according to the sites despite being found in one lesion. Our results showed
that the need for surgical debridement in each site was correlated with histological necrosis
without inflammatory cell infiltration, as the inflammation is supposed to represent an active
host immune response rather than mycobacterial burden. We suggest that the debridement
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of lesions with histological necrosis in mapping biopsy may be useful for Japanese cases
with unsuccessful standard antibiotic treatment to achieve sufficient clinical improvement.
Author summary
We have proposed a preoperative mapping biopsy procedure to perform optimal debride-
ment for Buruli ulcer presenting complicated skin lesions. Briefly, multiple punch biopsies
are performed from various sites around the Buruli ulcer lesions and the range of resec-
tion is decided according to the histological findings of the biopsies. Herein, we per-
formed histological examination and quantitative PCR analysis using 83 tissue samples
taken from mapping biopsy and debrided Buruli ulcer to validate our method. Our results
suggested that the sites with histological necrosis need to be resected during surgical
debridement and that the sites without histological necrosis can be preserved. These
results in combination with those of previous studies are supportive of the mapping
biopsy procedure that we have proposed. However, a randomized controlled study ques-
tioned the need for adjunct surgical treatment in Buruli ulcer. Further studies are needed
to establish the Japanese evidence for surgical treatment in Japanese cases of Buruli ulcer.
Introduction
Buruli ulcer is an ulcerative skin disease caused by Mycobacterium ulcerans infection. It has
been reported in more than 33 countries including Japan [1]. Japanese cases are caused by M.
ulcerans subspecies shinshuense [2]. Although the number of reported cases of Buruli ulcer in
Japan has been increasing, delayed diagnosis is frequent [3–6]. The lesions occur commonly
on the exposed area of the skin. Surgical treatment is performed in advanced cases in Japan in
spite of the “destructive” cosmetic and functional complications caused by extensive debride-
ment of large skin lesions on the exposed area, genitals, and breasts [7]. In addition, the para-
doxical reaction, which results from antibiotic treatment [7, 8], makes it more difficult to
determine the necessary and sufficient extent for resection. This phenomenon represents the
paradoxical worsening of Buruli ulcer lesions, which is observed after starting antibiotic treat-
ment. It may occur during or long after antibiotic treatment. In the past, it might have been
mistakenly diagnosed as recurrence or relapse [1].
We have proposed a mapping biopsy procedure to perform adequate debridement for
severe cases [3, 4, 9]. In these previous reports, multiple punch biopsies were performed from
various sites around the Buruli ulcer lesions for mapping biopsy. We demonstrated that
whether each site needs to be resected or preserved depends mainly on the histological find-
ings not on the presence of mycobacteria or their DNA. We recommend that the sites with his-
tologically massive necrosis must be resected during debridement and that the sites with
histological inflammatory cell infiltration without significant necrosis can be preserved. The
findings can be explained by mycolactone which is produced by M. ulcerans. Mycolactone is
an immunosuppressive toxin that causes massive necrosis of the dermis and subcutis without
inflammatory cell infiltration, which is the most characteristic histological feature of Buruli
ulcer.
For this study, we hypothesized that M. ulcerans proliferating in the early phase of infection
produces mycolactone to form less inflammatory necrotic lesions, whereas the decreased num-
ber of mycobacteria producing the toxin causes a host immune response in the skin [1, 10, 11].
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In this study, we aimed to investigate the relationship between mycobacterial burden and his-
topathological findings reflecting the host immune response and then to evaluate tissue dam-
age properly using our mapping biopsy procedure. We performed quantitative polymerase
chain reaction (PCR) analysis using our mapping biopsy samples in combination with histo-
pathological examination at each site.
Methods
Subjects
Three Japanese patients with Buruli ulcer treated at Shiga University of Medical Science from
2011 to 2016 were included in this descriptive study. The diagnosis of Buruli ulcer was based
on the compatible cutaneous manifestations, compatible histological findings, and positive
IS2404 amplification by PCR using DNA extracted from their skin tissue. Details of these cases
were reported previously [3, 4, 9]. The clinical appearances of the cases are shown in Fig 1A to
1C.
Fig 1. Clinical presentation of the four cases. (A–C) Clinical appearance of Cases 1–3, respectively. (A and B) Necrotic ulcers. Wide edema and erythema affected the
hand and forearm. (C) Oval necrotic ulcers with halo.
https://doi.org/10.1371/journal.pntd.0008051.g001
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Tissue samples for mycobacterial tests and histological examination
The first skin samples were taken from the edge of the ulcers for diagnosis and subjected to
histological examination with hematoxylin and eosin staining, and Ziehl-Neelsen staining,
DNA extraction, and mycobacterial culture tests using Ogawa egg medium. DNA-DNA
hybridization analysis using colorimetric microplate DNA-DNA hybridization ‘Kyokutou’
(Kyokutou, Tokyo, Japan) was performed in Case 1, in which the mycobacterial culture was
successful.
After the diagnosis was confirmed, mapping biopsy procedures were performed. In the case
of oval ulcer, tissue samples were taken from the sites 1 to 2 cm away in some directions from
the edge of the ulcer. In Case 3, 12 samples from six directions were taken. In Case 1, the first
mapping biopsy was performed to take four samples from sites 1–4 cm distant from the edge
of the ulcer. In Case 2, 10 samples were taken from sites 1–10 cm away from the necrotic
lesion. These procedures were performed to decide the ranges where debridement is required.
In complicated lesions composed of edematous erythema and necrotic ulcers, tissue samples
were taken from arbitrary sites on and around the gross lesions to determine the extent of
debridement. In Case 2, 10 samples were taken from sites located around the edematous ery-
thema lesion, not on the necrotic lesion. This was done to decide the range of resection. In
Case 1, the first mapping biopsy revealed that histological necrosis was distributed widely
throughout the dorsum of the hand. Thus, the second mapping biopsy was performed, and
seven samples were taken from the edge of the edema or erythema, which were located in the
palm and fingers.
In addition, a total of 84 tissue samples taken during debridement were analyzed. All tissue
samples obtained in mapping biopsies were resected as deeply as possible using a 4-mm
punch. The tissue samples were subjected to histological examination and DNA extraction as
described above. The resected skin in surgical debridement was also subjected to mycobacte-
rial tests and histological examination.
PCR analysis
DNA extraction was performed using DNeasy Blood and Tissue kit (Qiagen, Tokyo, Japan)
according to the manufacturer’s protocol. For the confirmation of the diagnosis, conventional
PCR targeting IS2404 (Genbank Accession number: KM459600.1) was performed in all cases
as described elsewhere [12]. Quantitative real-time PCR was performed using DNA extracted
from 29 samples taken from mapping biopsy to determine the quantities of IS2404 in each
skin sample and using the same primer pair as the conventional PCR and LightCycler 480 Sys-
tem II (Roche, Basel, Switzerland). The Cp values were determined by the second derivative
maximum method and normalized using human glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) to correct the difference due to the cell density of punch biopsy skin specimens. The
results of the quantitative PCR were examined descriptively in combination with the results of
mycobacterial tests and histological findings. Specific statistical analyses were not performed
due to the limited sample size.
Ethics statement
This study was approved by the Medical Ethics Committee of Shiga University of Medical Sci-
ence (approval number 30–103). We obtained written informed consent from all participants
of this study.
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Results
Subjects
The clinical features of our cases are shown in Table 1. All of them had ulcerative lesions on
their extremities, two cases showed edematous erythema widely distributed on their hands
and forearms with necrotic ulcers, and the other case showed oval ulcers with mild marginal
erythema. No cases had past histories of immunosuppressive diseases. Two cases had coexist-
ing methicillin-resistant Staphylococcus aureus infection.
All patients received empirical non-standard antibiotic treatment before they were accu-
rately diagnosed with Buruli ulcer. The combination of 800 mg/day of clarithromycin, 500
mg/day of levofloxacin, and 450 mg/day of rifampicin is recognized as the standard antibiotic
treatment against M. ulcerans in Japan [13]. Cefdinir, faropenem, ciprofloxacin, and minomy-
cin were used in Case 1; cefdinir, azithromycin, and minomycin were used in Case 2; and cef-
capene was used in Case 3. These drugs are not included in the Japanese standard regimen of
antibiotic treatment. Surgical debridement was performed in all cases as significant clinical
improvement was not achieved after starting standard chemotherapy and the patients could
not endure pain and distress. The lesions measured 5–15 cm in diameter. Surgical debride-
ment was performed twice in Case 1, twice in Case 2, and once in Case 3. Debridement was
performed based on our hypothesis that we should resect the sites with histological necrosis
and preserve the sites without histological necrosis, i.e., with histological inflammation alone.
All cases were cured after antibiotic and surgical treatments. We had to perform the second
debridement in cases showing clinically overt gross necrosis. In the other two cases, obvious
clinical evidence of paradoxical reaction was not observed.
Mycobacterial tests
The summary of mycobacterial tests is shown in the supplementary information.
In Cases 1 and 3, smear tests were positive in the initial biopsy specimens and in the sam-
ples taken from the subcutis during debridement. In Case 2, the smear test was negative in the
initial biopsy specimens. Smear tests using the subcutis sample taken during debridement
were positive. Ziehl-Neelsen staining was also positive in the initial biopsy specimens and in
the subcutis sample taken during debridement. In Case 1, mycobacterial culture tests using
fresh lesional samples revealed growth of yellow-white colonies in the Ogawa egg medium.
The skin samples were taken on the first visit (8 weeks after onset) and on the first debride-
ment (10 weeks after onset), and the mycobacterial growth was observed 4 and 7 weeks,
Table 1. Clinical features of three cases of Buruli ulcer.
Cases 1 2 3
Age (years) 19 26 33
Sex Male Male Male
Affected sites Dorsum of the left hand Left forearm and the elbow Dorsum of the right foot
Immunocompromised states No No No
Clinical manifestation Edematous erythema with necrotic ulcer Edematous erythema
with necrotic ulcer
Oval ulcer








Surgical treatment Twice Twice Once
https://doi.org/10.1371/journal.pntd.0008051.t001
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respectively, after the cultures started. DNA-DNA hybridization was positive for M. marinum.
In the other two cases, mycobacterial growth was not observed.
Histological examination
Histological examination was performed using 83 of the 84 tissue samples (56 from punch
biopsies and 28 from surgical debridement). One sample was subjected to DNA extraction and
mycobacterial tests without histological examination. Details of the samples are described in
the supplementary information.
In this study, we divided the histological findings into three patterns, that is, massive necro-
sis, dense inflammatory cell infiltration, and granuloma formation. The representative histo-
logical pictures of each pattern are shown in Fig 2A to 2F. In this respect, we described the
results of the histological examination in the supplementary information.
Inflammatory cell infiltration was the most frequent finding in our study. Of the 83 sam-
ples, 73 showed histological inflammation. Massive necrosis was observed in 45 samples. A
coexistence of necrosis and inflammation was observed in 35 samples. Therefore, 10 samples
showed histological necrosis without inflammation and 38 samples showed inflammation
without necrosis. Granuloma formation was always accompanied with inflammation. A coex-
istence of necrosis and granuloma formation was also observed. Necrosis was observed in the
sites near the center of the lesions or in the samples taken from debridement. Moreover, 43 of
83 samples were taken in mapping biopsies. As a result, necrosis alone, inflammation alone,
and their coexistence were observed in 2, 26, and 15 samples, respectively. Debridement was
performed so that the sites with histological necrosis were resected based on our hypothesis.
In Case 3, histological specimens of tissue samples in debridement were cut so that we
could evaluate them outwardly from the center of the lesion (or the ulcer) to the margin of the
lesion. The representative picture is shown in Fig 3A to 3C. Massive necrosis was observed in
the center of the lesion. Adjacent to the necrosis, dense inflammatory cell infiltration was
observed. Necrosis and hemorrhage coexisted with the infiltration. On the outside, the healthy
tissue gradually appeared.
In 34 sites, histological examination was performed more than once to mainly evaluate the
histological changes over time and to resect during debridement the sites where punch biopsy
was once performed. For example, Sample 9 in Case 1 was histologically examined once in
punch biopsy and was then resected during debridement followed by the second histological
examination as Sample 18. The observation of such sites revealed that no sites with histological
necrosis showed the disappearance of necrosis over time or after the administration of various
antibiotics. In addition, we found no tendency for the histological necrosis to decrease in sam-
ples taken even in the late phase of the disease or after antibiotic administration. In contrast, in
the 11 biopsied sites where histological necrosis was not observed, ulcers were cured and no
recurrence was observed even without resecting these sites.
Quantitative PCR
The results of the quantitative PCR are shown in bar charts (Fig 4A to 4C). Sites with low Cp
values in the quantitative PCR tended to show necrosis in the histological examination. Nota-
bly, in Case 3, Sites 64 and 68, where histological necrosis without inflammation was observed,
showed obviously lower Cp values than other sites.
Discussion
In our previous studies [3, 4, 9], we have tried to examine the relationship between mycobacte-
ria and histological changes in Buruli ulcer lesions based on only whether IS2404 amplification
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Fig 2. Representative histological findings of punch biopsies. (A and B) Sample 68 of Case 3 showed massive necrosis widely distributed in the deep dermis and
subcutis. Epidermis and superficial dermis were nearly intact, except for the unspecific perivascular inflammatory cell infiltration in the superficial dermis. Necrosis was
accompanied with scattered inflammatory cells and thrombus. This finding was recognized as necrosis (+), infiltrate (-), and granuloma (-) in the supplementary
information. Hematoxylin and eosin staining, original magnification, ×40 (A) and × 100 (B). (C and D) Sample 67 of Case 3 showed dense inflammatory cell infiltration
distributed over the entire dermis. Necrosis was not observed in this sample. (D) Inflammatory cells were mainly composed of lymphocytes and histiocytes. This finding
was recognized as necrosis (-), infiltrate (+), and granuloma (-) in the supplementary information. Hematoxylin and eosin staining, original magnification, ×100 (C) and
×200 (D). (E and F) Sample 71 of Case 3 showed mild inflammatory cell infiltration and granuloma formation in the dermis. This finding was recognized as necrosis (-),
infiltrate (+), and granuloma (+) in the supplementary information. Hematoxylin and eosin staining, original magnification, ×40 (E) and ×200 (F).
https://doi.org/10.1371/journal.pntd.0008051.g002
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was detected by conventional PCR. In the present study, we performed quantitative PCR for
IS2404 using DNA extracted from skin samples taken in our mapping biopsies. Quantitative
PCR for IS2404 using human samples was reported previously [14, 15]. Swab samples were
used, and a good correlation was demonstrated between the amount of M. ulcerans DNA in
extracts from swabs and the positivity of direct smear microscopy. As a result, the Cp values
were substantially different according to the sites. This result more clearly illustrated an
uneven distribution of mycobacterial DNA in the lesions compared to our previous results.
In the histopathology of Buruli ulcer, massive necrosis in the deep dermis and subcutis with
scant and unnoticeable inflammatory cell infiltration is well known [1, 16]. Dense inflamma-
tory cell infiltration mainly composed of lymphocytes and histiocytes is also frequently
observed. Infiltration around the sweat glands is often noted. This histological type is often
Fig 3. Histological findings of the skin resected during debridement. (A) Histology of the center of the ulcer. Massive necrosis forming the necrotic core was observed.
(B) Histology of the adjacent lesion of the ulcer. The epidermis was also gone, and dense inflammatory cell infiltration was observed on the background of necrosis. This
showed the infiltration belt surrounding the necrotic core. (C) Histology of the site 1 cm away from the ulcer. Epidermis was almost intact, except for the finding of
acanthosis. Inflammatory cell infiltration was mild compared to (B) and necrosis was not observed. This site was located outside of the infiltration belt. Hematoxylin and
eosin staining, original magnification, ×100.
https://doi.org/10.1371/journal.pntd.0008051.g003
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accompanied with necrosis and granuloma formation. As for the histological examination to
avoid unnecessary radical surgical resection, we have proposed performing the mapping
biopsy procedure before debridement, especially for cases with affected exposed area and joint
sites where performing extensive debridement is difficult [3, 4, 9]. As pointed out in our previ-
ous study [9], the center of the lesions showed massive necrosis, and adjacent to it, dense
inflammatory cell infiltration was observed. On the outside, densely infiltrated tissue transi-
tions to the healthy skin. Granulomas seemed to be formed later after inflammatory cell
infiltration.
Our proposal in previous studies is that the sites where necrosis is noted in mapping biopsy
needs to be resected and that those that showed inflammatory cell infiltration without histolog-
ical necrosis will be preserved. Ruf et al. who first described these histological characteristics
[8, 11, 16] called the central necrotic lesions as the necrotic core and the dense inflammatory
cell infiltration around the necrosis as the infiltration belt [8]. Our mapping biopsy, in other
words, intends to find the location of the infiltration belt and to resect the necrotic core. There-
fore, we think that our method corresponds to the findings of another previous study [3, 4, 9].
In our histological evaluation of 84 sites, 34 sites were evaluated histologically more than
once. Ruf et al. described that a partial infiltration of the affected tissue was observed after anti-
biotic treatment, whereas a damaged subcutis with extensive necrosis without major signs of
infiltration was observed before treatment [16]. However, as they have illustrated, the
Fig 4. Bar charts of the results of the quantitative PCR in Cases 1 to 3. The Y axis shows the relative Cp values normalized with human GAPDH. GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; PCR, polymerase chain reaction.
https://doi.org/10.1371/journal.pntd.0008051.g004
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histological difference resulted not from the simple effects of antibiotic treatment or the
changes over time but from the conflict between mycobacteria with immunosuppressive toxin
and host immune response [8]. As to this point, two studies also illustrated the histological
changes after antibiotic treatment [17, 18]. They described that highly organized lymphoid
structures or bands of inflammatory leucocytes were observed in Buruli ulcer patients after the
completion of the standard antibiotic treatment. They suggested that the histological changes
indicated the healing process and that such changes developed at the margins of the lesions.
Based on their conclusions, our method may be useful to clarify the border between the resid-
ual necrotic lesions and the healing sites after antibiotic treatment. In addition, our results sug-
gested that inflammatory infiltration was formed before the completion of the standard
antibiotic treatment. Antibiotics administered before an accurate diagnosis, which is not rec-
ognized as standard, may be also effective for mycobacteria.
Our histological examination based on mapping biopsies in combination with quantitative
PCR revealed a tendency that the Cp values were relatively lower in the sites with histological
necrosis than in the sites without necrosis. Especially, in Case 3, the Cp values were signifi-
cantly lower in sites where necrosis without structured inflammatory cell infiltration was the
major histological finding than those in sites with histological inflammation. However, in Case
1, Samples 13 and 15 showed relatively low Cp values, although they did not have histological
necrosis and could be preserved. We think that these results support the notion that large
amounts of immunosuppressive toxin produced by a lot of mycobacteria caused the histologi-
cal massive necrosis without inflammation and that decreased mycobacteria and toxin led to
the reconstitution of the host immune response. Therefore, we speculated that the sites show-
ing evidence that host immune response will work could be preserved even if mycobacteria
and their DNA are detected.
Based on our observations, we would like to emphasize the following three points. First,
none of the 34 sites described above showed the disappearance of histological necrosis. Ruf
et al. also described that large necrotic areas remained unchanged in spite of the completion of
the antibiotic treatment [16] and that the mycobacteria cannot be reached by the infiltrating
cells around the necrosis [8]. We speculated that the antibiotics cannot reach the necrotic core
without blood flow and that the necrotic core must be resected once it was widely formed. Sec-
ond, none of the 11 sites that showed histologically inflammatory cell infiltration needed to be
resected to cure the ulcers. The result suggests that if the necrotic core inside is sufficiently
removed, the sites with the infiltration belt can be preserved. Here, the host immune response
and antibiotics can eliminate the mycobacteria. However, a histological finding of dermal infil-
tration and subcutaneous necrosis is often observed. Sites showing this histological pattern
may need debridement, as they contain a part of the necrotic core to be resected. Finally, the
conflict between mycobacteria and host immune response, which is reflected as the difference
in histological findings, will vary in each site even if the biopsies are performed from one
patient at the same time. For example, in the mapping biopsy of Case 3, Samples 64 and 68,
which were taken at 1 cm away from the edge of the ulcers, showed significant necrosis. In
contrast, Samples 60, 62, 66, and 70, which were also taken at sites 1 cm away, showed inflam-
matory cell infiltration with granuloma formation. This can be understood considering the
existence of the infiltration belt; however, for example, in Samples 9–15, various sites on the
left hand showed histologically inflammatory cell infiltration without necrosis, whereas the site
on the wrist (Sample 10) only showed necrosis regardless of the distance from the center of the
lesion. In such complicated cases, the obvious location of the single infiltration belt cannot be
determined. This suggests that the conflict between mycobacteria and host immune response
is not a single event but occurs everywhere around the lesion. We speculate that host immune
response on one site may fail to eliminate the mycobacteria to form necrotic lesions, whereas
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host immune response on the other site prevents the spread of mycobacteria. The latter will
show an inflammatory cutaneous manifestation, which presents clinically, for example, as an
edematous erythema or a paradoxical reaction. Complicated lesions such as Cases 1 and 2
might be formed in this manner.
As regards the surgical intervention for cases with Buruli ulcer, a randomized controlled
study was performed, which showed that delaying the decision to perform surgery did not
delay the healing rate and increase residual functional limitations [19]. Moreover, even large
ulcers can heal without surgical intervention. Therefore, our decision at the time, i.e., whether
each site needs debridement or not, was based on the assumption derived from the analysis of
the biopsy, not on the clinical evidence. We speculate that the results of the clinical trial in an
African setting may not completely be applicable to Japanese cases, as surgical treatment is
more accessible and the cosmetic results are highly appreciated in Japan. Clinical evidence of
the surgical treatment for Japanese cases with Buruli ulcer is scarce due to the rarity of the dis-
ease. In Japanese cases, surgical treatment is recommended especially when the diagnosis is
delayed [13, 20]. Our cases were accurately diagnosed after months of evaluation. The first
biopsies were performed from 6 to 13 weeks after onset. Inflammatory cell infiltration was his-
tologically recognized first in the samples taken 10, 6, and 13 weeks after onset respectively in
three cases. Therefore, we suggested that the host immune response may begin from this
period. However, antibiotic treatment alone failed to achieve obvious improvement in our
three cases, and we decided to perform debridement.
This study has some limitations. First, Japanese cases with Buruli ulcer are extremely rare.
Therefore, the sample size of the current study is small and the study is based on a Japanese set-
ting. Further investigation is required to validate the efficiency of our histological mapping
Fig 5. Outline of our mapping biopsy method.
https://doi.org/10.1371/journal.pntd.0008051.g005
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method. As described above, in an African setting, a randomized controlled study questioned
the need for adjunct surgical debridement in treating Buruli ulcer. Hereafter, the establishment
of clinical evidence for the surgical treatment of Japanese Buruli ulcer cases is required. More-
over, our mapping biopsy is based on the Japanese situation in which histological services are
relatively accessible and histological examination results are obtained in a week. Second, the
spatial distribution of M. ulcerans in skin tissue is uneven [15]. They are known to be located
primarily in the subcutis. The sizes of our skin samples, in other words the sizes of the resected
subcutis, may have some influence on the results of the quantitative PCR. To avoid such influ-
ence, we tried to correct the Cp values using human GAPDH. However, we must recognize
that punch biopsies may not always be helpful as mycobacteria are not evenly distributed.
In this study, we performed descriptive analysis of the histological findings and amounts of
mycobacterial DNA in each site of Buruli ulcer lesions. In conclusion, the amounts of myco-
bacterial DNA were shown to differ substantially according to the sites even though they
belonged to one lesion. Our study also showed that the histological findings differed signifi-
cantly even though the samples were taken simultaneously from nearby sites. The results in
combination with previous studies are supportive of our mapping biopsy procedure. Multiple
skin biopsies will provide the information on the location of the necrotic core and infiltration
belt. Based on the results, the necrotic core must be resected during surgical debridement, but
it can be preserved outside of the infiltration belt. Fig 5 illustrates the outline of our method.
We believe that the method is preferable in particular for cases with complicated lesions that
are composed of edematous erythema and necrotic ulcer, and performing extensive surgical
debridement is difficult due to cosmetic and functional reasons.
Supporting information
S1 Table. Summary of the analysis of 84 tissue samples. The results of mycobacterial and
histological examination and PCR analysis are shown.
(XLSX)
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